- Home
- ORIC vs DGICB Comparison
ORIC vs DGICB Comparison
Compare ORIC & DGICB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ORIC | DGICB |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | 851 |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 861.3M | 889.2M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ORIC | DGICB |
|---|---|---|
| Price | $12.02 | $21.60 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 13 | 0 |
| Target Price | ★ $19.73 | N/A |
| AVG Volume (30 Days) | ★ 1.6M | 8.6K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 3.34% |
| EPS Growth | ★ 19.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $2.26 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $8.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $7.23 | $13.84 |
| 52 Week High | $14.93 | $29.99 |
Technical Indicators
Market Signals| Indicator | ORIC | DGICB |
|---|---|---|
| Relative Strength Index (RSI) | 70.89 | 48.73 |
| Support Level | $11.74 | $15.43 |
| Resistance Level | $12.58 | $23.69 |
| Average True Range (ATR) | 0.73 | 1.51 |
| MACD | 0.07 | -0.52 |
| Stochastic Oscillator | 87.22 | 13.59 |
Price Performance
Historical ComparisonAbout ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About DGICB Donegal Group Inc. Class B
Donegal Group Inc is an insurance holding company whose insurance subsidiaries and affiliates offer property and casualty insurance in 21 Mid-Atlantic, Midwestern, Southern, and Southwestern states. It includes three segments: Investments Function, Commercial Lines of Insurance, and Personal Lines of Insurance. The majority of revenue is from the commercial Lines segment. The commercial Lines segment consists mainly of commercial automobile, commercial multi-peril, and workers' compensation policies.